Partner Headlines - BIIB

  1. Earnings Scheduled For October 22, 2014

    Benzinga
  2. Biogen Leads 5 Top Biotech Stocks As Earnings Loom

    IBD
  3. Yahoo, Super Micro Rally After Hours

    IBD
  4. Celgene Reports More Good Crohn's Disease Data

    IBD
  5. Celgene's Crohn's Disease Drug Hits Its Marks

    IBD
  6. Celgene, Alexion Among 4 IBD 50 Medical s To Report

    IBD
  7. Baxter Q3 Beats As Hemophilia Drugs Fend Off Rivals

    IBD
  8. IPO Stock Watch: Biotech Forward Pharma Falls On IPO

    IBD
  9. Major Averages Pare Losses, Then Head Lower Again

    IBD
  10. IBD 50: Medical, Internet Companies Top Q3 Estimates

    IBD
  11. IPO Calendar: Biotech Companies Lead List Of 7 IPOs

    IBD
  12. Which Fund Has The Most To Gain From Biogen Idec?

    Benzinga
  13. IBD 50: Medical, Internet Companies Top Q3 Profit Estimates

    IBD
  14. Most Top Industry Groups Fall Harder Than Market

    IBD
  15. Biogen Idec Inc's Stock Is Set To Drop

    Benzinga
  16. Second Oldest Stock Fund Is As Nimble As A Teenager

    IBD
  17. Top Fund Buys: Chipotle, Allergan, Jazz, Gilead

    IBD
  18. Ebola Diagnosis in U.S. Raises Pharmaceutical Stock by 20%

    GuruFocus
  19. Biogen Idec Inc Still Showing Relative Weakness Compared To Biotech ...

    Benzinga
  20. Biotech Stocks Rebound On Strong Earnings, New Drugs

    IBD
  21. Large-Cap Tech, Biotech Names Hang Tough In Shaky Market

    IBD
  22. New MS Drugs Offer Promise

    IBD
  23. Multiple Sclerosis Drugs Could Transform Market Again

    IBD
  24. Technology Stocks Slide But Other Sectors Hold Up Better

    IBD
  25. A Few Reasons Why AbbVie's Momentum Will Continue

    GuruFocus
  26. Stocks Get Hit Hard; GoPro, Skechers Buck Weakness

    IBD
  27. Wave Of Selling Hits Stocks; IPO CyberArk Extends Gains

    IBD
  28. Apple Fuels Tech Sell-Off; Valeant Bucks The Trend

    IBD
  29. Stocks End Skid; Vertex, Alexion Lead Biotech Rebound

    IBD
  30. Stocks Up In Afternoon; Hasbro Jumps On Disney Deal

    IBD
  31. Acorda To Buy Civitas, Gains Parkinson's Disease Drug

    IBD
  32. Stocks Hold Solid Gains; CyberArk Soars In Debut

    IBD
  33. Most Big Cap 20 Stocks Near Entries, But Risks Exist

    IBD
  34. Gilead's Zydelig Approved In EU; Imbruvica In Wings

    IBD
  35. 2 Columbia Growth Funds Notch Impressive Three-Month Performance

    Benzinga
  36. Nasdaq Falls Hard, But Apple Resilient On iPhone Orders

    IBD
  37. Gilead, Jazz, Salix Among Top 6 IBD 50 Drugmakers

    IBD
  38. Why Nine of Fifteen Oil Majors Are Undervalued

    YCharts
  39. Medivation Eyes Blockbuster As Cancer Drug Gets An OK

    IBD
  40. Stocks Show Modest Losses; Biotechs Pressured Again

    IBD
  41. Biogen Idec Inc Suddenly Struggling To Keep Up With The Biotech ...

    Benzinga
  42. Biogen Reports PLEGRIDY Two-Year Data Confirms Maintenance of ...

    Benzinga
  43. Biogen Announces Five-Year Results from ENDORSE Phase 3 Study ...

    Benzinga
  44. Stocks Turn Higher After Soft Start; U.S. Silica Jumps

    IBD
  45. ReceptosMS Drug Yields More Good Data; Stock Jumps

    IBD
  46. Steadier, Better: 35 Years Of Low-Volatility Stocks

    YCharts
  47. Allianz's Analyst Likes Biogen, Celgene & Gilead

    Benzinga
  48. Indexes Trim Losses But Remain Lower At Midday

    IBD
  49. Biogen: Moving From Collaboration To Innovation

    IBD
  50. Economic Data Fuel Another All-Time High For S&P 500

    IBD
  51. Celgene, Gilead Lead Big Biotech Stock Movers

    IBD
  52. Biogen, Celgene In Buy Range; LinkedIn Coming Back

    IBD
  53. Stocks Hold Decent Gains; InterMune Deal Sparks Biotechs

    IBD
  54. Majority Of IBD 50 Firms Strong On Sponsorship

    IBD
  55. Biogen's buy rating reaffirmed

    IBD
  56. UPDATE: Morgan Stanley Reiterates On Biogen Idec Following Plegridy ...

    Benzinga
  57. Perrigo Regains Some Lost Ground On Fiscal Q4 Beat

    IBD
  58. Perrigo Q4 Beats Estimates, But Guidance Misses

    IBD
  59. Tech, Health Care Lead Q2 Earnings Beats

    IBD
  60. #PreMarket Primer: Friday, August 8: U.S. To Begin Airstrikes ...

    Benzinga
  61. Top 4 Stocks In The Biotechnology Industry With The Highest Revenue

    Benzinga
  62. Why Investors Should Closely Watch Celgene

    Benzinga
  63. Biotech Gets A Lift On Popular Drug, Strong Pipeline

    IBD
  64. Ken Fisher's Top Increaes of the Second Quarter

    GuruFocus
  65. Ken Fisher's Top Increases of the Second Quarter

    GuruFocus
  66. Chipotle, Facebook Rally On Upside Earnings Surprise

    IBD
  67. Celgene, Alexion Beat Estimates, But Biotechs Fall

    IBD
  68. Celgene, Alexion Earnings Top Street, But Stocks Fall

    IBD
  69. Biogen, Gilead Profits Soar

    IBD
  70. Biogen, Gilead Crush Earnings Estimates On Hot Drugs

    IBD
  71. S&P 500 Posts New High; Biotechs, Airlines, Builders Up

    IBD
  72. IPO Stock Watch: Biotechs Are Half Of July Calendar

    IBD
  73. Vertex Is Poised For An Earnings Breakout

    Benzinga
  74. Pepsi Beats; Positive Phase 3 Breast Cancer Data Creates Potential ...

    Benzinga
  75. S&P 500 Flirts With High; Breadth Missing On Nasdaq

    IBD
  76. Intuitive Surgical Rises On Upbeat Earnings; Xilinx Shares Slip

    Benzinga
  77. S&P 500 Aims At New High; Biotechs Gap Up In Fast Trade

    IBD
  78. Biogen Trounces Q2 Estimates As Tecfidera Outperforms

    IBD
  79. Apple, Microsoft Lead Nasdaq Higher; Dow Falters

    IBD
  80. Markets Mixed; PepsiCo Q2 Earnings Beat Street View

    Benzinga
  81. Stocks: Mixed Open, Mixed Trade; Delta, Broadcom, Biogen Buck ...

    IBD
  82. Morning Market Movers

    Benzinga
  83. UPDATE: Biogen Idec Posts Stronger-Than-Expected Q2 Results, ...

    Benzinga
  84. Stock Futures Up, But Wobbly; Boeing, Apple, Biogen Rising

    IBD
  85. Benzinga's Top #PreMarket Gainers

    Benzinga
  86. Earnings Scheduled For July 23, 2014

    Benzinga
  87. Stocks Rise; Apple, Microsoft Steady In Post-Session

    IBD
  88. Alexion, 3 Other Top Biotechs Reporting Earnings

    IBD
  89. Stocks Climb In Solid Trade; Chipotle Gaps Up, Breaks Out

    IBD
  90. Oil Dominates; Keurig, Constellation Near Buy Points

    IBD
  91. IBD 50 Ends Week Lower But Skyworks Soars

    IBD
  92. Biogen Shares Rebound As Street Has A Change Of Heart

    IBD
  93. Facebook, Gilead Headline IBD 50's Top 5 Earnings

    IBD
  94. IBD 50 Ends Week Lower But Skyworks Soars

    IBD
  95. Biotech Enters Reporting Season With Large Caps Central To Sector ...

    Benzinga
  96. Baxter Q2 Earnings Beat Estimates, But Guidance Soft

    IBD
  97. IBD Big Cap 20 Leaders Hold Up Well Despite Shaky Market

    IBD
  98. Biogen's Profit Rolls Amid Recent Drug Launches

    IBD
  99. Stocks Close Higher As Biotech, Internet Stocks Gain

    IBD
  100. Deutsche Bank Analyst Talks Up Biogen On CNBC; Stock Responds ...

    Benzinga
Trading Center